While the reduction of PSMA levels, as detected by 68Ga-PSMA PET/CT, in hormone-naïve cancer might be due to more effective tumor shrinkage by enzalutamide, ARB in advanced PC might result in PSMA induction with weaker anti-tumor effects. Here, FOLH1 is linked to pachyonychia congenita.